UP: Rs 70 lakh fine on Regency Hospital, directors

Published On 2018-09-30 06:33 GMT   |   Update On 2018-09-30 06:33 GMT

Uttar Pradesh: Sebi has slapped a total penalty of Rs 70 lakh on Uttar Pradesh-based Regency Hospital as well as its two promoters for fraudulent trading in the company's shares.


In two separate orders issued on Friday, Sebi imposed fine of Rs 15 lakh on Regency Hospital, and Rs 25 lakh each on Managing Director  Atul Kapoor and Whole Time Director Rashmi Kapoor.






Additionally, Rs 5 lakh was imposed on Regency for failing to disclose to the exchange about information received from its promoters regarding their pledged securities. The watchdog examined the movement of the scrip during the period from


April to September 2011. Subsequently, it was found that the firm and the directors along with other connected entities executed synchronised trades, reversal trades and self-trades among themselves, resulting in artificial volumes.

"Noticees employed and induced the services of the connected entities to trade among themselves to show an appearance of volume in the market by also executing structured, synchronised, reversal and self-trades to show artificial volume.


"This was also coupled with the impact on traded prices by executing first trades for the day so as to set the price for trading day, contributing the price rise in the scrip," regulator said.


The noticees are Regency Hospital and the two directors.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News